Page last updated: 2024-10-15

sethoxydim

Description

sethoxydim: structure given in Merck Index [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135491830
CHEBI ID81815
SCHEMBL ID33669
SCHEMBL ID6642242
MeSH IDM0141634

Synonyms (62)

Synonym
sethoxydim
74051-80-2
grasidim
sethoxydim [bsi:iso]
sn 81742
brn 5955471
expand
epa pesticide chemical code 121001
bas 9052
2-cyclohexen-1-one, 2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxy-
np 55
2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxy-2-cyclohexen-1-one
caswell no. 072a
cyethoxydim
bas 90520h
tritex-extra
fervinal
hsdb 7342
sethoxydime [iso-french]
nabu
bas 9052h
einecs 277-682-3
2-(1-(ethoxyimino)butyl)-5-(2-ethylthiopropyl)-3-hydroxycyclohex-2-en-1-one
checkmate
(+-)-(ze)-2-(1-ethoxyiminobutyl)-5-(2-(ethylthio)propyl)-3-hydroxycyclohex-2-enone
poast
NCGC00164468-01
chebi:81815 ,
2-[1-(ethoxyamino)butylidene]-5-(2-ethylsulfanylpropyl)cyclohexane-1,3-dione
C18539
sethoxydime
unii-1189nnq8f6
1189nnq8f6 ,
tox21_301052
dtxcid604304
dtxsid9024304 ,
cas-74051-80-2
NCGC00254954-01
sethoxydim [iso]
alloxol s
cyethoxydim [hsdb]
sertin
sethoxydim [mi]
2-(1-ethoxyiminobutyl)-5-(2-(ethylthio)propyl)-3- hydroxycyclohex-2-enone, (+/-)-(ze)-
2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxy- 2-cyclohexen-1-one
AKOS025311496
SCHEMBL33669
SCHEMBL6642242
2-[(1e)-n-ethoxybutanimidoyl]-5-[2-(ethylsulfanyl)propyl]-1,3-cyclohexanedion
W-104434
71441-80-0
2-[(1e)-n-ethoxybutanimidoyl]-5-[2-(ethylsulfanyl)propyl]cyclohexane-1,3-dione
2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxycyclohex-2-enone
sethoxydim, pestanal(r), analytical standard
(e)-2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxycyclohex-2-enone
2-[(e)-n-ethoxy-c-propylcarbonimidoyl]-5-(2-ethylsulfanylpropyl)-3-hydroxycyclohex-2-en-1-one
sethoxydim peak 1
1,3-cyclohexanedione, 2-[1-(ethoxyamino)b
DTXSID7058466
1262311-71-6
ZCA05180
AKOS040744786

Dosage Studied

ExcerptReference
" Dose-response experiment indicated that Lujiang population was highly resistant to fenoxaprop-p-ethyl (199."( Target-site mechanism of ACCase-inhibitors resistance in American sloughgrass (Beckmannia syzigachne Steud.) from China.
Du, L; Li, L; Liu, W; Wang, J; Yuan, G, 2014
)
" Dose-response experiments showed that the AHSX-1 population has evolved a very high level resistance to fenoxaprop-p-ethyl (RI = 275) and mesosulfuron-methyl (RI = 788)."( Multiple resistance to ACCase and AHAS-inhibiting herbicides in shortawn foxtail (Alopecurus aequalis Sobol.) from China.
Bi, Y; Du, L; Guo, W; Li, Q; Liu, W; Wang, J; Yuan, G; Zhang, C, 2015
)
" In this study, whole-plant dose-response assays were conducted to investigate the level of resistance in four resistant American sloughgrass populations (LY, JH, BYJ and BYP) to four ACCase-inhibiting herbicides belonging to aryloxyphenoxypropionates, cyclohexanediones, and phenylpyrazolines groups under greenhouse conditions."( Resistance of American sloughgrass (Bechmannia syzigachne) populations to ACCase-inhibiting herbicides involves three different target site mutations from China.
Chen, J; Tang, W; Zhang, Y; Zhou, F, 2015
)
" Dose-response experiments revealed that the MR1 population was 45."( Multiple resistance to glyphosate, paraquat and ACCase-inhibiting herbicides in Italian ryegrass populations from California: confirmation and mechanisms of resistance.
Jasieniuk, M; Jugulam, M; Nandula, V; Putta, K; Tehranchian, P, 2018
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic hydroxy compoundAn organic compound having at least one hydroxy group attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (20)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency30.82490.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency43.90300.000221.22318,912.5098AID743036
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency54.81530.001022.650876.6163AID1224839
progesterone receptorHomo sapiens (human)Potency61.50380.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency67.72160.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency11.70070.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency48.85420.005428.02631,258.9301AID1346982
thyroid stimulating hormone receptorHomo sapiens (human)Potency51.74900.001628.015177.1139AID1224895
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00250.010039.53711,122.0200AID588547
heat shock protein beta-1Homo sapiens (human)Potency55.27050.042027.378961.6448AID743210
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Acetyl-CoA carboxylase 1 Rattus norvegicus (Norway rat)IC50 (µMol)40.00000.05300.17880.5900AID30370
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
adenylate cyclase activityAdenylate cyclase type 3Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneAdenylate cyclase type 3Rattus norvegicus (Norway rat)
plasma membraneAdenylate cyclase type 8Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID3443Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD)1999Bioorganic & medicinal chemistry letters, Feb-22, Volume: 9, Issue:4
Inhibition of 4-hydroxyphenylpyruvate dioxygenase by sethoxydim, a potent inhibitor of acetyl-coenzyme A carboxylase.
AID30370Inhibitory concentration against rat heart ACC by the carboxylation of acetyl-CoA with [14C]-HCO3- to form [14C]-malonyl CoA; 18-40 uM2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
AID3448Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM)1999Bioorganic & medicinal chemistry letters, Feb-22, Volume: 9, Issue:4
Inhibition of 4-hydroxyphenylpyruvate dioxygenase by sethoxydim, a potent inhibitor of acetyl-coenzyme A carboxylase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.06)18.7374
1990's5 (15.15)18.2507
2000's7 (21.21)29.6817
2010's16 (48.48)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]